Fifth Third Bancorp reduced its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 454,999 shares of the pharmacy operator’s stock after selling 60,967 shares during the quarter. Fifth Third Bancorp’s holdings in Walgreens Boots Alliance were worth $33,169,000 as of its most recent filing with the SEC.
Several other hedge funds also recently bought and sold shares of WBA. Bank of New York Mellon Corp boosted its holdings in shares of Walgreens Boots Alliance by 71,970.7% during the third quarter. Bank of New York Mellon Corp now owns 11,640,855 shares of the pharmacy operator’s stock worth $848,617,000 after purchasing an additional 11,624,703 shares during the period. Franklin Resources Inc. boosted its holdings in shares of Walgreens Boots Alliance by 21.5% during the third quarter. Franklin Resources Inc. now owns 18,789,390 shares of the pharmacy operator’s stock worth $1,369,796,000 after purchasing an additional 3,318,524 shares during the period. LSV Asset Management raised its position in Walgreens Boots Alliance by 28.5% during the third quarter. LSV Asset Management now owns 11,183,914 shares of the pharmacy operator’s stock valued at $815,307,000 after acquiring an additional 2,479,681 shares in the last quarter. FMR LLC raised its position in Walgreens Boots Alliance by 41.9% during the third quarter. FMR LLC now owns 5,640,694 shares of the pharmacy operator’s stock valued at $411,206,000 after acquiring an additional 1,665,402 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in Walgreens Boots Alliance by 11.5% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,110,617 shares of the pharmacy operator’s stock valued at $666,804,000 after acquiring an additional 1,143,819 shares in the last quarter. Institutional investors and hedge funds own 62.59% of the company’s stock.
In other news, EVP Kathleen Wilson-Thompson sold 52,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total value of $4,096,040.00. Following the transaction, the executive vice president now owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Nancy M. Schlichting sold 7,050 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total transaction of $555,610.50. Following the completion of the transaction, the director now directly owns 5,709 shares in the company, valued at approximately $449,926.29. The disclosure for this sale can be found here. In the last three months, insiders sold 73,756 shares of company stock worth $5,824,194. Insiders own 14.80% of the company’s stock.
Several equities analysts recently weighed in on WBA shares. TheStreet raised shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Tuesday, September 25th. BidaskClub lowered shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, August 28th. Loop Capital raised their price objective on shares of Walgreens Boots Alliance from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, October 12th. Finally, Barclays raised their price objective on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research report on Friday, October 12th. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $79.11.
NASDAQ:WBA opened at $81.19 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $59.07 and a 12 month high of $86.31. The company has a market capitalization of $78.72 billion, a PE ratio of 13.49, a PEG ratio of 1.29 and a beta of 0.76. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, beating the Zacks’ consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. The company had revenue of $33.44 billion for the quarter, compared to analyst estimates of $33.64 billion. Analysts predict that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date of this dividend is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Derivative
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.